Actually Liposomal Glutathione, expertly formulated in the UK
Given that asthma is a recognized risk factor for COPD, it is reasonable to postulate that genetic variations in ORs can also influence an individuals susceptibility to COPD
In vitro studies using normal human epidermal keratinocytes revealed that treatment with glutathione amino acid precursors significantly increased both GSH and glutathione disulfide levels, leading to an improved GSH/glutathione disulfide ratio, which is a key indicator of cellular redox balance
This set point progressively becomes lower as we age resulting in suboptimal glutathione production
Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, Sturm I, et al
Excellent support Easy to order, arrived quickly and customer service was available for a quick question I had